ESTHMR إستثمر

Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda RMDA

العاشر من رمضان للصناعات الدوائية والمستحضرات تشخيصية-راميدا

Health Care & PharmaceuticalsEgyptian Exchange

5.45 EGP

+1.87%

Close of Thu 1 Oct 2026

Market value
EGP 11.08bn
Highest and lowest close in a year
3.09 – 6.94
Shares traded in the session
7,195,956
Open the full company record in ESTHMR

A chart of every session, the financial statements, the nine checks and filing alerts. Free, with your e-mail and a six-digit code.

About the company

Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda is a healthcare company operating within pharmaceuticals, biotechnology, and life sciences. Established in January 1986 and based in 6th of October, Egypt, it has been listed on the EGX since December 2019. Major shareholders include Equinox Pharma Holding Limited (19.2743%), LVP Pharma (11.7675%), and Saudi Seventh Investment (11.1546%). It holds stakes in Rameda Pharmaceutical Trading, Glow, Ramecare, and Ramepharma.

Facts from Mubasher

Its record at the exchange

Across 397 exchange filings from 2019 to 2026, the company generated 37 reported periods of profit and zero loss-making periods. Reported net profit peaked at 402 million EGP in FY 2024, compared to a record low of 24 million EGP in Q1 2020. Filing activity peaked in 2022 with 93 submissions. Its record includes 5 capital-increase filings, 6 bonus share filings, and two trading suspensions with subsequent resumptions.

Its latest filings at the exchange

  1. Shareholders' meetingTenth of Ramadan Pharmaceutical Industries and Diagnostic Reagents - Rameda (RMDA.CA) - Minutes of the Extraordinary General Assembly Meeting (Notarized)
  2. Shareholders' meetingTenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents - Ramida (RMDA.CA) - Minutes of the Extraordinary General Meeting (Unnotarized)
  3. Shareholders' meetingTenth of Ramadan Pharmaceutical Industries and Diagnostic Reagents - Ramida (RMDA.CA) - Summary of Extraordinary General Assembly resolutions
  4. Shareholders' meetingTenth of Ramadan Pharmaceutical Industries and Diagnostic Reagents - Ramida (RMDA.CA) - Ordinary General Assembly Meeting Minutes (Unnotarized)

Insider trades in the exchange’s bulletin

As the exchange publishes them in each session’s bulletin: the trader’s capacity, not their name. Each row opens the bulletin itself.

  1. Connected Group Sold300,000 (0.01% of the company)Bulletin ↗
  2. Insider / Board Sold616,846 (0.03% of the company)Bulletin ↗
  3. Connected Group Sold700,000 (0.03% of the company)Bulletin ↗
  4. Insider / Board Sold2,050,000 (0.10% of the company)Bulletin ↗
  5. Connected Group Sold300,000 (0.01% of the company)Bulletin ↗
  6. Insider / Board Sold35,000 (less than 0.01% of the company)Bulletin ↗
  7. Insider / Board Sold250,000 (0.01% of the company)Bulletin ↗
  8. Insider / Board Sold3,500,000 (0.17% of the company)Bulletin ↗
  9. Insider / Board Sold1,018,726 (0.05% of the company)Bulletin ↗
  10. Connected Group Sold500,000 (0.02% of the company)Bulletin ↗

Other companies in Health Care & Pharmaceuticals

Page updated with the data of 1 Oct 2026.